CD86 functions as a co-inhibitory receptor to drive CD8⁺ T-cell exhaustion and is associated with poor immune recovery in chronic HIV-1 infection

Chronic HIV-1 infection is characterized by persistent CD8⁺ T-cell exhaustion, which impedes effective viral control and serves as a major barrier to achieving complete immune reconstitution in people living with HIV (PLWH) receiving suppressive antiretroviral therapy (ART). While classic co-inhibitory receptors are central to this process, the functional plasticity of canonical co-stimulatory molecules in driving T-cell exhaustion remains underexplored. Here, we investigated the role of T cell-intrinsic CD86, a member of the B7 family traditionally recognized as a co-stimulatory ligand on antigen-presenting cells (APCs), in T-cell exhaustion during HIV-1 infection. Flow cytometry was performed to assess CD86 expression on CD8⁺ T cells and to characterize their phenotypic, functional, and intracellular signaling profiles. HIV-1-specific responses were evaluated following peptide pool stimulation, and cytokine stimulation assays in vitro were used to identify factors promoting CD86 upregulation. Bulk RNA sequencing (RNA-seq), qRT-PCR, and analysis of publicly available single-cell RNA-seq (scRNA-seq) datasets were employed to characterize transcriptional features and provide external validation. We identified a significantly elevated frequency of CD86⁺CD8⁺ T cells in treatment-naive PLWH, which strongly correlated with HIV-1 disease progression and persistent immune activation. Phenotypic and functional analyses, supplemented by scRNA-seq, revealed that these cells exhibited a profound exhaustion program, characterized by upregulation of co-inhibitory receptors, impaired effector function, and distinct transcriptional reprogramming. We identified IL-15 as a key driver of intrinsic CD86 upregulation, linking excessive proliferation-driven replicative stress with functional impairment during HIV-1 infection. Mechanistically, we demonstrated that T cell-intrinsic CD86 functioned as a non-canonical co-inhibitory receptor that drove exhaustion via reverse signaling, which suppressed the Akt-mTOR and NF-κB (p50) signaling pathways. Furthermore, high baseline frequencies of CD86⁺CD8⁺ T cells showed potential predictive value for poor immune recovery after ART. Our findings established CD86 as a novel regulator of CD8⁺ T-cell exhaustion and highlighted its potential as a biomarker for predicting immune reconstitution in PLWH. These insights offer a new perspective on the functional plasticity of co-inhibitory molecules and identify CD86 as a potential target for therapeutic intervention.

Authors

Institutions

Publication Details

Journal
Cell Communication and Signaling
Published
2026-11-20
DOI
https://doi.org/10.1186/s12964-026-03372-3
Primary Topic
HIV Research and Treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

CD86 functions as a co-inhibitory receptor to drive CD8⁺ T-cell exhaustion and is associated with poor immune recovery in chronic HIV-1 infection

孔雅娴, Zhijiao He, Qiyao Pu, Xinyue Wang et al.
Cell Communication and Signaling
HIV Research and Treatment
article

CD86 functions as a co-inhibitory receptor to drive CD8⁺ T-cell exhaustion and is associated with poor immune recovery in chronic HIV-1 infection

孔雅娴, Zhijiao He, Qiyao Pu, Xinyue Wang, Mengyuan Zhang, Yixuan Cao, Chuan Song, Meng Zhao, Jiangyan Yuan, Hongxin Zhao, Meiqing Jiang
article en

Abstract

Chronic HIV-1 infection is characterized by persistent CD8⁺ T-cell exhaustion, which impedes effective viral control and serves as a major barrier to achieving complete immune reconstitution in people living with HIV (PLWH) receiving suppressive antiretroviral therapy (ART). While classic co-inhibitory receptors are central to this process, the functional plasticity of canonical co-stimulatory molecules in driving T-cell exhaustion remains underexplored. Here, we investigated the role of T cell-intrinsic CD86, a member of the B7 family traditionally recognized as a co-stimulatory ligand on antigen-presenting cells (APCs), in T-cell exhaustion during HIV-1 infection. Flow cytometry was performed to assess CD86 expression on CD8⁺ T cells and to characterize their phenotypic, functional, and intracellular signaling profiles. HIV-1-specific responses were evaluated following peptide pool stimulation, and cytokine stimulation assays in vitro were used to identify factors promoting CD86 upregulation. Bulk RNA sequencing (RNA-seq), qRT-PCR, and analysis of publicly available single-cell RNA-seq (scRNA-seq) datasets were employed to characterize transcriptional features and provide external validation. We identified a significantly elevated frequency of CD86⁺CD8⁺ T cells in treatment-naive PLWH, which strongly correlated with HIV-1 disease progression and persistent immune activation. Phenotypic and functional analyses, supplemented by scRNA-seq, revealed that these cells exhibited a profound exhaustion program, characterized by upregulation of co-inhibitory receptors, impaired effector function, and distinct transcriptional reprogramming. We identified IL-15 as a key driver of intrinsic CD86 upregulation, linking excessive proliferation-driven replicative stress with functional impairment during HIV-1 infection. Mechanistically, we demonstrated that T cell-intrinsic CD86 functioned as a non-canonical co-inhibitory receptor that drove exhaustion via reverse signaling, which suppressed the Akt-mTOR and NF-κB (p50) signaling pathways. Furthermore, high baseline frequencies of CD86⁺CD8⁺ T cells showed potential predictive value for poor immune recovery after ART. Our findings established CD86 as a novel regulator of CD8⁺ T-cell exhaustion and highlighted its potential as a biomarker for predicting immune reconstitution in PLWH. These insights offer a new perspective on the functional plasticity of co-inhibitory molecules and identify CD86 as a potential target for therapeutic intervention.

Cell Communication and Signaling
Capital Medical University (CN), Peking University (CN), National Institute for Communicable Disease Control and Prevention (CN), Beijing Ditan Hospital (CN)
Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support
Good health and well-being
HIV Research and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon